NASDAQ:BSGM - BioSig Technologies Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $8.11 -0.38 (-4.48 %) (As of 05/19/2019 04:00 PM ET)Previous Close$8.11Today's Range$7.70 - $8.4652-Week Range$3.50 - $9.97Volume359,836 shsAverage Volume183,028 shsMarket Capitalization$163.90 millionP/E RatioN/ADividend YieldN/ABeta0.76 ProfileAnalyst RatingsChartEarningsInsider TradesInstitutional OwnershipHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email BioSig Technologies, Inc., a development stage medical device company, engages in developing a proprietary biomedical signal processing technology platform to extract information from physiologic signals. Its product is PURE (Precise Uninterrupted Real-time evaluation of Electrograms) EP System, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes, and displays electrocardiogram and electrograms required during electrophysiology studies and catheter ablation procedures. It is also developing a library of software tools that are designed to be configured to fit the needs of electrophysiologists in various settings and for arrhythmia treatments. The company was founded in 2009 and is headquartered in Los Angeles, California. Receive BSGM News and Ratings via Email Sign-up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:BSGM Previous Symbol CUSIPN/A CIKN/A Webwww.biosig.com Phone310-620-9320Debt Debt-to-Equity Ratio0.02 Current Ratio10.99 Quick Ratio10.99Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.50 per share Price / Book16.22Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-17,250,000.00 Net MarginsN/A Return on Equity-354.26% Return on Assets-284.49%Miscellaneous Employees20 Outstanding Shares20,210,000Market Cap$163.90 million Next Earnings Date7/26/2019 (Estimated) OptionableNot Optionable BioSig Technologies (NASDAQ:BSGM) Frequently Asked Questions What is BioSig Technologies' stock symbol? BioSig Technologies trades on the NASDAQ under the ticker symbol "BSGM." How were BioSig Technologies' earnings last quarter? BioSig Technologies Inc (NASDAQ:BSGM) announced its quarterly earnings results on Monday, April, 15th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.30) by $0.03. View BioSig Technologies' Earnings History. When is BioSig Technologies' next earnings date? BioSig Technologies is scheduled to release their next quarterly earnings announcement on Friday, July 26th 2019. View Earnings Estimates for BioSig Technologies. What price target have analysts set for BSGM? 2 brokerages have issued 1-year price targets for BioSig Technologies' shares. Their predictions range from $11.00 to $14.00. On average, they expect BioSig Technologies' share price to reach $12.50 in the next twelve months. This suggests a possible upside of 54.1% from the stock's current price. View Analyst Price Targets for BioSig Technologies. What is the consensus analysts' recommendation for BioSig Technologies? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for BioSig Technologies. Has BioSig Technologies been receiving favorable news coverage? News articles about BSGM stock have trended somewhat positive recently, according to InfoTrie Sentiment. The research group rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. BioSig Technologies earned a news sentiment score of 1.9 on InfoTrie's scale. They also gave news stories about the company a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days. Who are some of BioSig Technologies' key competitors? Some companies that are related to BioSig Technologies include BioLife Solutions (BLFS), Semler Scientific (SMLR), Rockwell Medical (RMTI), Cutera (CUTR), Zynex (ZYXI), Fonar (FONR), Stereotaxis (STXS), Second Sight Medical Products (EYES), Edap Tms (EDAP), electroCore (ECOR), IRIDEX (IRIX), Soleno Therapeutics (SLNO), Helius Medical Technologies (HSDT), Viveve Medical (VIVE) and Precision Optics (PEYE). What other stocks do shareholders of BioSig Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Roku (ROKU), Amarin (AMRN), Gilead Sciences (GILD), Ocular Therapeutix (OCUL), Intel (INTC), Twitter (TWTR), NVIDIA (NVDA), Neurocrine Biosciences (NBIX), Actinium Pharmaceuticals (ATNM) and Eguana Technologies (EGT). Who are BioSig Technologies' key executives? BioSig Technologies' management team includes the folowing people: Mr. Kenneth L. Londoner M.B.A., MBA, Founder, CEO & Exec. Chairman (Age 51)Mr. Steven Chaussy, Chief Financial Officer (Age 65)Ms. Lora Mikolaitis, VP of Admin. (Age 46)Mrs. Tiffini Wittwer, Chief Regulatory & Compliance OfficerMr. John Kowalski, VP of Sales Who are BioSig Technologies' major shareholders? BioSig Technologies' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Zeke Capital Advisors LLC (1.03%), Cambridge Investment Research Advisors Inc. (0.45%), Jefferies Group LLC (0.41%), Cornerstone Wealth Group LLC (0.30%), BlackRock Inc. (0.29%) and Northern Trust Corp (0.06%). Company insiders that own BioSig Technologies stock include Andrew Lawrence Filler, Donald E Foley, Joseph Rafferty, Kenneth L Londoner, Lora Mikolaitis, Patrick Joseph Gallagher and Steve Chaussy. View Institutional Ownership Trends for BioSig Technologies. Which institutional investors are selling BioSig Technologies stock? BSGM stock was sold by a variety of institutional investors in the last quarter, including Zeke Capital Advisors LLC. View Insider Buying and Selling for BioSig Technologies. Which institutional investors are buying BioSig Technologies stock? BSGM stock was purchased by a variety of institutional investors in the last quarter, including Jefferies Group LLC, Cornerstone Wealth Group LLC, BlackRock Inc., Cambridge Investment Research Advisors Inc., Northern Trust Corp and Morgan Stanley. Company insiders that have bought BioSig Technologies stock in the last two years include Andrew Lawrence Filler, Donald E Foley, Joseph Rafferty, Kenneth L Londoner, Patrick Joseph Gallagher and Steve Chaussy. View Insider Buying and Selling for BioSig Technologies. How do I buy shares of BioSig Technologies? Shares of BSGM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is BioSig Technologies' stock price today? One share of BSGM stock can currently be purchased for approximately $8.11. How big of a company is BioSig Technologies? BioSig Technologies has a market capitalization of $163.90 million. BioSig Technologies employs 20 workers across the globe. What is BioSig Technologies' official website? The official website for BioSig Technologies is http://www.biosig.com. How can I contact BioSig Technologies? BioSig Technologies' mailing address is 12424 WILSHIRE BOULEVARD SUITE 745, LOS ANGELES CA, 90025. The company can be reached via phone at 310-620-9320 or via email at [email protected] MarketBeat Community Rating for BioSig Technologies (NASDAQ BSGM)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 28 (Vote Outperform)Underperform Votes: 27 (Vote Underperform)Total Votes: 55MarketBeat's community ratings are surveys of what our community members think about BioSig Technologies and other stocks. Vote "Outperform" if you believe BSGM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BSGM will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/19/2019 by MarketBeat.com StaffFeatured Article: Understanding Relative Strength Index Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.